VIR · NASDAQ · Biotechnology

VirBio (VIR)

Develops immune-based medicines for chronic hepatitis delta, solid tumors, and HIV cure research.

$11.61
After hours+0.12 (+1.02%)
At close$11.49(+5.63%)